Literature DB >> 27626384

Immunology: Channelling potassium to fight cancer.

K George Chandy1, Raymond S Norton2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27626384     DOI： 10.1038/nature19467

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).

Authors:  Palle Christophersen; Heike Wulff
Journal:  Channels (Austin)       Date:  2015-07-28       Impact factor: 2.581

2.  Memory T cell-driven differentiation of naive cells impairs adoptive immunotherapy.

Authors:  Christopher A Klebanoff; Christopher D Scott; Anthony J Leonardi; Tori N Yamamoto; Anthony C Cruz; Claudia Ouyang; Madhu Ramaswamy; Rahul Roychoudhuri; Yun Ji; Robert L Eil; Madhusudhanan Sukumar; Joseph G Crompton; Douglas C Palmer; Zachary A Borman; David Clever; Stacy K Thomas; Shashankkumar Patel; Zhiya Yu; Pawel Muranski; Hui Liu; Ena Wang; Francesco M Marincola; Alena Gros; Luca Gattinoni; Steven A Rosenberg; Richard M Siegel; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2015-12-14       Impact factor: 14.808

Review 3.  Adoptive cell transfer as personalized immunotherapy for human cancer.

Authors:  Steven A Rosenberg; Nicholas P Restifo
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

Review 4.  The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review.

Authors:  Colin H Richards; Zahra Mohammed; Tahir Qayyum; Paul G Horgan; Donald C McMillan
Journal:  Future Oncol       Date:  2011-10       Impact factor: 3.404

Review 5.  Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?

Authors:  Christopher A Klebanoff; Luca Gattinoni; Nicholas P Restifo
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

Review 6.  Combination cancer immunotherapy and new immunomodulatory targets.

Authors:  Kathleen M Mahoney; Paul D Rennert; Gordon J Freeman
Journal:  Nat Rev Drug Discov       Date:  2015-08       Impact factor: 84.694

7.  A phase 0 trial of riluzole in patients with resectable stage III and IV melanoma.

Authors:  Dana Yip; Maithao N Le; Joseph L-K Chan; Jonathan H Lee; Janice A Mehnert; Anthony Yudd; Jeffery Kempf; Weichung J Shih; Suzie Chen; James S Goydos
Journal:  Clin Cancer Res       Date:  2009-05-19       Impact factor: 12.531

Review 8.  The functional network of ion channels in T lymphocytes.

Authors:  Michael D Cahalan; K George Chandy
Journal:  Immunol Rev       Date:  2009-09       Impact factor: 12.988

9.  Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1.

Authors:  Cecilia L Speyer; Mahdy A Nassar; Ali H Hachem; Miriam A Bukhsh; Waris S Jafry; Rafa M Khansa; David H Gorski
Journal:  Breast Cancer Res Treat       Date:  2016-05-04       Impact factor: 4.872

10.  Ionic immune suppression within the tumour microenvironment limits T cell effector function.

Authors:  Robert Eil; Suman K Vodnala; David Clever; Christopher A Klebanoff; Madhusudhanan Sukumar; Jenny H Pan; Douglas C Palmer; Alena Gros; Tori N Yamamoto; Shashank J Patel; Geoffrey C Guittard; Zhiya Yu; Valentina Carbonaro; Klaus Okkenhaug; David S Schrump; W Marston Linehan; Rahul Roychoudhuri; Nicholas P Restifo
Journal:  Nature       Date:  2016-09-14       Impact factor: 49.962
  10 in total
  10 in total

1.  Multi-marker analysis of genomic annotation on gastric cancer GWAS data from Chinese populations.

Authors:  Fei Yu; Tian Tian; Bin Deng; Tianpei Wang; Qi Qi; Meng Zhu; Caiwang Yan; Hui Ding; Jinchen Wang; Juncheng Dai; Hongxia Ma; Yanbing Ding; Guangfu Jin
Journal:  Gastric Cancer       Date:  2018-06-01       Impact factor: 7.370

2.  Reply to Levis and Rendini.

Authors:  Dhiraj Kumar Singh; Ved Prakash Dwivedi; Anand Ranganathan; William R Bishai; Luc Van Kaer; Gobardhan Das
Journal:  J Infect Dis       Date:  2017-05-01       Impact factor: 5.226

3.  Tissue resident memory T cells in the human conjunctiva and immune signatures in human dry eye disease.

Authors:  Tanima Bose; Ryan Lee; Aihua Hou; Louis Tong; K George Chandy
Journal:  Sci Rep       Date:  2017-03-27       Impact factor: 4.379

Review 4.  Ion channels as therapeutic antibody targets.

Authors:  Catherine J Hutchings; Paul Colussi; Theodore G Clark
Journal:  MAbs       Date:  2018-12-10       Impact factor: 5.857

5.  The Trials and Tribulations of Structure Assisted Design of KCa Channel Activators.

Authors:  Heesung Shim; Brandon M Brown; Latika Singh; Vikrant Singh; James C Fettinger; Vladimir Yarov-Yarovoy; Heike Wulff
Journal:  Front Pharmacol       Date:  2019-09-20       Impact factor: 5.810

Review 6.  Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy.

Authors:  Verena Hofschröer; Karolina Najder; Micol Rugi; Rayhana Bouazzi; Marco Cozzolino; Annarosa Arcangeli; Gyorgy Panyi; Albrecht Schwab
Journal:  Front Pharmacol       Date:  2021-01-19       Impact factor: 5.810

7.  Amplifying STING activation by cyclic dinucleotide-manganese particles for local and systemic cancer metalloimmunotherapy.

Authors:  Xiaoqi Sun; Yu Zhang; Jiaqian Li; Kyung Soo Park; Kai Han; Xingwu Zhou; Yao Xu; Jutaek Nam; Jin Xu; Xiaoyue Shi; Lei Wei; Yu Leo Lei; James J Moon
Journal:  Nat Nanotechnol       Date:  2021-09-30       Impact factor: 40.523

8.  KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.

Authors:  Brandon M Brown; Brandon Pressley; Heike Wulff
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Tuning Scorpion Toxin Selectivity: Switching From KV1.1 to KV1.3.

Authors:  Andrei M Gigolaev; Alexey I Kuzmenkov; Steve Peigneur; Valentin M Tabakmakher; Ernesto L Pinheiro-Junior; Anton O Chugunov; Roman G Efremov; Jan Tytgat; Alexander A Vassilevski
Journal:  Front Pharmacol       Date:  2020-07-07       Impact factor: 5.810

Review 10.  Molecular biochemical aspects of salt (sodium chloride) in inflammation and immune response with reference to hypertension and type 2 diabetes mellitus.

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2021-08-01       Impact factor: 3.876
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.